Telomir Pharmaceuticals TELO Cash Flow Statement (2022-2026)

NASDAQ TELO
$1.04 +0.03 (+2.97%)
As of: Oct 21, 2026 · 11:32 AM EDT
Reported Financials

Telomir Pharmaceuticals Quarterly Cash Flow Statement

Periods 14 quarters
Latest Jun 2026

Telomir Pharmaceuticals cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 14 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income -0.48M-1.55M-1.71M-9.33M-6.25M-1.39M-5.99M-2.90M-2.18M-5.07M-1.10M-2.01M-1.72M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.74M0.74M4.34M
Share-based CompensationStock Comp. 2.09M1.40M4.66M-0.74M0.59M
Other non-cash itemsOther Non-Cash 0.01M7.47M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp. -0.25M1.39M-1.05M0.02M0.07M-0.08M0.11M0.08M-0.03M-0.30M0.07M0.68M
Change in Other Operating AssetsOther Assets Change -250.000.10M-0.01M-0.01M-0.02M0.03M-0.01M0.00M-0.02M
Other Working Capital ChangesOther WC Changes 250.00-0.10M0.01M0.01M0.02M-0.03M0.01M0.00M0.02M
Cash from OperationsCash from Ops. -0.74M-0.03M-2.00M-1.09M-1.94M-1.52M-1.00M-0.61M-0.90M-0.66M-0.94M-1.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment 0.26M0.32M0.52M-0.09M
Non-Current Debt -0.26M-0.32M0.95M-0.52M0.09M1.00
Short-Term Debt issuancesST Debt Issuance 0.85M0.11M
Short-Term Debt repaymentsST Debt Repayment 0.10M
Current Debt 0.85M0.11M-0.10M
Net Debt Issuances and RepaymentsNet Debt Issuance -0.26M-0.32M0.85M1.07M-0.62M0.09M1.00
Change in Capital Stock
Common Stock IssuedStock Issued 1.00M-0.09M0.09M5.83M1.04M4.50M4.00M0.00M
Net Shares Issued and RepurchasedNet Shares Issued 1.00M-0.09M0.09M5.83M1.04M4.50M4.00M0.00M
Net Equity Issued and RepurchasedNet Equity Issued 1.00M-0.09M0.09M5.83M1.04M4.50M4.00M0.00M
Other financing activitiesOther financing -0.02M-0.20M
Cash from Financing ActivitiesCash from Financing 0.74M0.05M1.99M1.09M5.21M0.13M-0.05M1.04M7.50M1.16M
Additional items
Change in Cash 388.000.01M-0.01M0.00M3.27M-1.39M-1.05M0.43M-0.86M0.35M6.57M-0.04M
Ending Cash Balance 0.00M0.00M0.01M0.00M0.00M3.27M1.88M0.83M1.27M0.40M0.75M7.33M7.29M5.17M
Free Cash FlowFCF -0.74M-0.03M-2.00M-1.09M-1.94M-1.52M-1.00M-0.61M-0.90M-0.66M-0.94M-1.20M
Net Cash FlowNCF 388.000.01M-0.01M0.00M3.27M-1.39M-1.05M0.43M-0.90M-0.66M6.56M-0.04M

Telomir Pharmaceuticals Cash Flow Statement API

Pull Telomir Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TELO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY